Pulmodyne
Generated 5/10/2026
Executive Summary
Pulmodyne is a privately held medical device manufacturer based in Indianapolis, specializing in disposable airway and respiratory management products for acute care, emergency/prehospital, and homecare markets. Founded in 2007, the company offers a portfolio of intuitive devices including manual resuscitators, CPAP systems, atomization devices, and emergency surgical airway kits. Pulmodyne operates in a competitive but fragmented market, benefiting from rising respiratory disease prevalence and growing demand for emergency preparedness. While the company lacks publicly available financial data, its focus on rapid-administration design positions it for steady adoption in hospital and prehospital settings. Near-term growth is likely driven by product line extensions and strategic partnerships to expand distribution. Given the private nature, direct investment opportunities are limited; however, monitoring regulatory clearances and commercial agreements can provide insight into market traction.
Upcoming Catalysts (preview)
- Q3 2026FDA 510(k) Clearance for Next-Generation Disposable CPAP System70% success
- Q4 2026Exclusive Distribution Agreement with Major National Hospital Group60% success
- Q2 2026Launch of Enhanced Emergency Surgical Airway Kit80% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)